Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Merck & Co (NY: MRK )

72.62 USD -2.00 (-2.68%)
Official Closing Price Updated: 7:59 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
5 Deep Value Dividend Stocks For Annual Portfolio Rebalancing
Buying stocks with high dividend yields is good–buying undervalued dividend stocks with growth potential is even better. 
Tags Stocks / Equities Market News
From Blogs - TalkMarkets
Are These The Top Biotech Stocks To Buy In March? 4 Names To Consider
Tags Market News
From Stockmarket.com
FDA Requires Additional Data On Merck COVID-19 Drug, EUA Moved Back
Merck & Co Inc(NYSE:MRK) had reported a significant snag in its latest annual filing (10K), wherein the company has ... 
Tags Benzinga Market News FDA
From Benzinga
Buy This Blue Chip on the Dip
Here's how you can take advantage of the latest sell-off in a stalwart pharma stock. 
Tags Market News MRK BMY
From Motley Fool
Buffett Just Bought $8 Billion Of This 5G Stock
Want to know which nine stocks, including some dividend stocks, that Buffett has been buying and possibly the best stocks to buy now? 
Tags Stocks / Equities Market News
From Blogs - TalkMarkets
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags INCY SUPN APYX
From Benzinga
Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg
The European Medical Agency (EMA) is reportedly set to recommendJohnson & Johnson’s(NYSE:JNJ) coronavirus ... 
Tags BNTX AZN Top Stories
From Benzinga
Why Pandion Therapeutics Stock Shot Up 133% Today
Pandion Therapeutics Inc (NASDAQ: PAND) shares closed over 133% higher today. What Happened: Pandion — a developer of novel ... 
Tags Market News Small Cap Biotech
From Benzinga
Why Pandion Therapeutics Stock Blasted Sky-High on Thursday
You'd vault into the air too if a big-name pharmaceutical paid a high premium for your stock. 
Tags Market News MRK
From Motley Fool
Merck Animal Health Completes Acquisition of Poultry Sense Limited
Merck Animal Health Completes Acquisition of Poultry Sense Limited 
From Business Wire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Investigates Pandion Therapeutics, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Pandion Therapeutics, Inc. ("Pandion" or the "Company") (NASDAQ: PAND) in... 
From PR Newswire
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Pandion Therapeutics, Inc. Buyout
From GlobeNewswire News Releases
PANDION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PAND and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
April 9th Options Now Available For Merck (MRK)
Investors in Merck & Co Inc (MRK) saw new options begin trading today, for the April 9th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK options chain for... 
Tags Stocks
From Market News Video
Why Merck Is Buying Autoimmune Disease Drug Company Pandion For $1.85B
Merck & Co., Inc. (NYSE: MRK) is making another big-ticket buy, this time to expand its presence in the autoimmune disease ... 
Tags Movers Benzinga News
From Benzinga
PAND Stock: Why Pandion Therapeutics Shares Have Skyrocketed Today
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Pandion Therapeutics (PAND) stock is soaring higher on Thursday after... 
Tags PAND Market News NASDAQ:PAND,NYSE:MRK
From InvestorPlace
Pandion Therapeutics Surges To Record High On Merck's $1.85 Billion Buyout
Pandion Therapeutics stock blasted to a record high Thursday on Merck's plan to buy the IPO stock for $1.85 billion. Pandion just recently wrapped its initial public offering in July. 
From Investor's Business Daily
Merck To Acquire Pandion Therapeutics For $60 Per Share In Cash
Merck and Pandion Therapeutics announced that the companies have entered into a definitive agreement, under which Merck, through a subsidiary, will acquire Pandion. 
Tags Market News Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Penny Stocks NTUS EDIT
From Benzinga
The Math Shows XPH Can Go To $68
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Merck to Acquire Pandion Therapeutics
Merck to Acquire Pandion Therapeutics 
From Business Wire News Releases
Moderna Raises 2021 Base COVID-19 Vaccine Production Plan To 700M Doses
Moderna Inc(NASDAQ:MRNA) said it wasmaking new capital investmentsto increase manufacturing capacity, and ... 
Tags COVID/19 Vaccine PFE Benzinga
From Benzinga
Moderna To Test New COVID-19 Vaccine Targeting South Africa Strain
Moderna Inc(NASDAQ:MRNA) isexperimenting with several potential methodsof combating the new COVID-19 virus ... 
Tags South Africa COVID/19 Vaccine CVAC
From Benzinga
There's More to Merck's New 'Bean Counter' CEO Than First Appears
The former chief financial officer has some experience in operations as well. 
Tags Market News MRK
From Motley Fool
How to Invest Like Warren Buffett in 2021
There are multiple ways to invest like The Oracle of Omaha. 
Tags MRK BRK/A MMC
From Motley Fool
Merck to Present at the Cowen 41st Annual Health Care Conference
Merck to Present at the Cowen 41st Annual Health Care Conference 
From Business Wire News Releases
Veru Files US Application For TADFIN Combo For Prostate Enlargement
Veru Inc(NASDAQ:VERU) hassubmitted a 505(b)(2) New Drug Applicationwith the FDA for TADFIN (tadalafil 5mg and ... 
Tags General VERU MRK
From Benzinga
FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants
Amid concerning virus variants, the FDA said it would quickly analyze any vaccine booster shots against COVID-19 variants. The ... 
Tags COVID/19 Vaccine CVAC SHTDY
From Benzinga
XLV, JNJ, PFE, MRK: ETF Outflow Alert
Symbols mentioned in this story: XLV, JNJ, PFE, MRK Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Lantern Pharma CEO Discusses The Addition Of Its New ADC Program And The Resurgence Of ADC Therapy For Cancer Treatment
The following article is sponsored by Lantern Pharma. The information contained in this article in no way represents investment advice ... 
Tags Market News GILD Markets
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.